EUVIMEDEUVIMED entdecken
Crossref

Circulating miRNA-4701-3p as a predictive biomarker of cardiovascular disease which induces angiogenesis by inhibition of TOB2

Seung Min Lee, Bo Hyun Yoon, Jin Woo Lee, I Jin-Yong Jeong, Inki Kim, Chan-Gi Pack, Young-Hak Kim, Chang Hoon Ha

Microvascular Research · 2024

DOI: 10.1016/j.mvr.2024.104698 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microvascular Research, 2024. Verfasst von Seung Min Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Convergence Medicine and Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republi…. Hauptthemen laut MEDLINE: Human Umbilical Vein Endothelial Cells, MicroRNAs, Neovascularization, Physiologic, MEF2 Transcription Factors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Asan Institute for Life Sciences, Asan Medical Center, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Angiogenesis is mainly regulated by the delivery of VEGF-dependent signaling to cells. However, the angiogenesis mechanism regulated by VEGF-induced miRNA is still not understood. After VEGF treatment in HUVECs, we screened the changed miRNAs through small-RNA sequencing and found VEGF-induced miR-4701-3p. Furthermore, the GFP reporter gene was used to reveal that TOB2 expression was regulated by miR-4701-3p, and it was found that TOB2 and miR-4701-3p modulation could cause angiogenesis in an in-vitro angiogenic assay. Through the luciferase assay, it was confirmed that the activation of the angiogenic transcription factor MEF2 was regulated by the suppression and overexpression of TOB2 and miR-4701-3p. As a result, MEF2 downstream gene mRNAs that induce angiogenic function were regulated. We used the NCBI GEO datasets to reveal that the expression of TOB2 and MEF2 was significantly changed in cardiovascular disease. Finally, it was confirmed that the expression of circulating miR-4701-3p in the blood of myocardial infarction patients was remarkably increased. In patients with myocardial infarction, circulating miR-4701-3p was increased regardless of age, BMI, and sex, and showed high AUC levels in specificity and sensitivity analysis (AUROC) (AUC = 0.8451, 95 % CI 0.78-0.90). Our data showed TOB2-mediated modulation of MEF2 and its angiogenesis by VEGF-induced miR-4701-3p in vascular endothelial cells. In addition, through bioinformatics analysis using GEO data, changes in TOB2 and MEF2 were revealed in cardiovascular disease. We suggest that circulating miR-4701-3p has high potential as a biomarker for myocardial infarction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Human Umbilical Vein Endothelial CellsMicroRNAsNeovascularization, PhysiologicMEF2 Transcription FactorsHumansMaleFemaleVascular Endothelial Growth Factor ASignal TransductionMyocardial InfarctionCells, CulturedGene Expression RegulationCase-Control StudiesMiddle AgedDatabases, GeneticIntracellular Signaling Peptides and ProteinsTumor Suppressor ProteinsAngiogenesis

Stichwörter der Autor:innen

AngiogenesisBlood biomarkerCirculating miRNAEndothelial cellMyocardial infarctionVEGF

Substanzen

MicroRNAsMEF2 Transcription FactorsVascular Endothelial Growth Factor AIntracellular Signaling Peptides and ProteinsTumor Suppressor ProteinsVEGFA protein, human

Autor:innen und Institutionen

  • Department of Convergence Medicine and Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Convergence Medicine and Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; ConveRgence mEDIcine research cenTer (CREDIT), Asan Instit…
  • Cardiology Division, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: mdyhkim@amc.seoul.kr.
  • Department of Convergence Medicine and Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: chhoonha@amc.seoul.kr.

Förderung

  • Asan Institute for Life Sciences, Asan Medical Center
  • National Research Foundation of Korea

Zitieren

APA

Lee, S. M., Yoon, B. H., Lee, J. W., Jeong, I. J., Kim, I., Pack, C. G., Kim, Y. H., & Ha, C. H. (2024). Circulating miRNA-4701-3p as a predictive biomarker of cardiovascular disease which induces angiogenesis by inhibition of TOB2. Microvascular Research. https://doi.org/10.1016/j.mvr.2024.104698

Vancouver

Lee SM, Yoon BH, Lee JW, Jeong IJ, Kim I, Pack CG, et al. Circulating miRNA-4701-3p as a predictive biomarker of cardiovascular disease which induces angiogenesis by inhibition of TOB2. Microvascular Research. 2024. doi:10.1016/j.mvr.2024.104698

BibTeX
@article{Lee2024,
  author = {Lee, Seung Min and Yoon, Bo Hyun and Lee, Jin Woo and Jeong, I Jin-Yong and Kim, Inki and Pack, Chan-Gi and Kim, Young-Hak and Ha, Chang Hoon},
  title = {Circulating miRNA-4701-3p as a predictive biomarker of cardiovascular disease which induces angiogenesis by inhibition of TOB2},
  journal = {Microvascular Research},
  year = {2024},
  doi = {10.1016/j.mvr.2024.104698}
}
Kostenlos starten →